Serine proteinase inhibitor 9 can be recognized by cytotoxic T lymphocytes of epithelial cancer patients

Japanese Journal of Cancer Research

Volumn 93, Issue 2, 2002, Pages 198-208

  Tanaka, Koji ^a   Harashima, Nanae ^a   Niiya, Fumihiko ^b   Miyagi, Yoshiaki ^b   Hida, Naoya ^a   Ochi, Mika ^a   Imai, Nobue ^a   Harada, Mamoru ^a   Itoh, Kyogo ^a   Shichijo, Shigeki ^a  

^a Department of Immunology ^*  (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CTLs; Peptide; PI 9; Serpin

Indexed keywords

COMPLEMENTARY DNA; EPITOPE; GRANZYME B; HLA A ANTIGEN; HLA ANTIGEN CLASS 1; INTERLEUKIN 1BETA CONVERTING ENZYME; SERINE PROTEINASE INHIBITOR;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER PATIENT; COLON CANCER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA ISOLATION; DNA LIBRARY; DNA SCREENING; ENZYME ACTIVITY; ESOPHAGUS CANCER; FIBROBLAST; GENE EXPRESSION; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN TISSUE; INHIBITION KINETICS; LEUKEMIA; LEUKEMIA CELL LINE; LUNG CANCER; MOLECULAR RECOGNITION; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; STOMACH CANCER; T LYMPHOCYTE; TUMOR CELL;

BASE SEQUENCE; CLONING, MOLECULAR; EPITOPES, T-LYMPHOCYTE; HLA-A ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASMS, GLANDULAR AND EPITHELIAL; SERPINS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0036118893     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2002.tb01259.x     Document Type: Article

References (37)

1. A gene encoding an antigen recognized by cytotoxic T lymphocytes on a human melanoma
2. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2 restricted tumor infiltrating lymphocytes
3. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection
4. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
5. A mutated β-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes
6. A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanoma is encoded by an intron sequence of the N-acetylglucosaminyltranferase V gene
7. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma
8. Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocytes (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage
9. Breast and ovarian cancer-specific cytotoxic T lymphocytes recognized the same HER-2/neu-derived peptide
10. Identification of an immunodominant peptide of HER-2/neu proto-oncogene recognized by ovarian tumor-specific cytotoxic T lymphocytes lines
11. Generation of human cytolytic T lymphocyte lines directed against prostate-specific antigen (PSA) employing a PSA oligoepitope peptide
12. In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen
13. Identification of an HLA-A11-restricted epitope from the tandem repeat domain of the epithelial tumor antigen mucin
14. Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine
15. A gene encoding antigenic peptide of human squamous cell carcinoma recognized by cytotoxic T lymphocytes
16. Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL
17. Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients
18. A new tumor-rejection antigen recognized by cytotoxic T lymphocytes infiltrating into a lung adenocarcinoma
19. Identification of a new endoplasmic reticulum-resident protein recognized by HLA-A24-restricted tumor-infiltrating lymphocytes of lung cancer
20. A cyclophilin B gene encodes antigenic epitopes recognized by HLA-A24-restricted and tumor-specific CTLs
21. Human proteinase inhibitor 9 (P19) is a potent inhibitor of subtilisin A
22. A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier is a present in cytotoxic lymphocytes
23. A new family of 10 murine ovalbumin serpins induces two homologs of proteinase inhibitor 8 and two homologs of the granzyme B inhibitor (Proteinase inhibitor 9)
24. Proteinase inhibitor 9, an inhibitor of granzyme B-mediated apoptosis, is a primary estrogen-inducible gene in human liver cells
25. Selective regulation of apoptosis: The cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway
26. Identification of a SART-1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes
27. Role of strong anchor residues in the effective binding of 10-mer and 11-mer peptides to HLA-A2402 molecules
28. Peptide binding to MHC class I molecules: Implications for antigenic peptide predictions
29. Conserved CTL epitopes within EBV latent membrane protein 2
30. Direct binding of peptide to empty MHC class I molecules on intact cells and in vitro
31. The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin-1β-converting enzyme (Caspase-1) activity is human vascular smooth muscle cells
32. Caspase-1 (interleukin-1β-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9
33. Molecular cloning expression, and partial characterization of two novel members of the ovalbumin family of serine proteinase inhibitors
34. The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites
35. Recognition of the Lck tyrosinase kinase as a tumor antigen by cytotoxic T lymphocytes of cancer patients with distant metastases
36. + T effector cells by dendritic cells pulsed with protein or selected peptides
37. Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients